Lysosomal dysfunction is described as reduced lysosomal acid lipase (LAL) activity, disturbed lysosomal acidification and lysosomal permeabilization and has been reported in NAFLD. Here, LIPA is linked to metabolic dysfunction-associated steatotic liver disease.